Linked Life Data

2812763

Source:http://linkedlifedata.com/resource/pubmed/id/2812763

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
44
pubmed:dateCreated
1989-12-8
pubmed:abstractText
Fifty patients with acute deep vein thrombosis, pulmonary embolism, acute myocardial infarct and priapism were treated with subcutaneous calcium heparin. Laboratory control was based on the examination of APTT. On the first day of heparin therapy only 52% of patients's APTT was 1.5 times greater than control value but the ratio increased to 82% on the fifth day of treatment. The importance of initial venous sodium heparin bolus (5-10,000 U) followed immediately by subcutaneous calcium heparin is emphasized. Injection of 500 U/kg/day calcium heparin divided in two equal doses is recommended. Four thrombotic and two haemorrhagic complications were observed. Subcutaneous calcium heparin can substitute the intravenous form of heparin (either bolus or continuous) in the treatment of thromboembolism.
pubmed:language
hun
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0030-6002
pubmed:author
pubmed:issnType
Print
pubmed:day
29
pubmed:volume
130
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2347-9
pubmed:dateRevised
2009-10-21
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
[Subcutaneous heparin-calcium therapy: clinical and laboratory experience].
pubmed:publicationType
Journal Article, English Abstract